Addition of incretin therapy to metformin in type 2 diabetes.
Scheen
André J
AJ
University of Liège, Division of Diabetes, Nutrition and Metabolic Disorders and Clinical Pharmacology Unit, Department of Medicine, CHU Sart Tilman, B-4000 Liège, Belgium. andre.scheen@chu.ulg.ac.be
Radermecker
Régis P
RP
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D052216:Glucagon-Like Peptide 1; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D054795:Incretins / Q000627:therapeutic use*; D008687:Metformin / Q000627:therapeutic use*
D007004:Hypoglycemic Agents; D054795:Incretins; D052216:Glucagon-Like Peptide 1; D008687:Metformin